Evofem Biosciences, Inc.
Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100, an antimicrobial vaginal gel for the prevention of urogenital transmission of Chlamydia trachomatis infection and Neisseria gonorrhoeae infection in women. It has a collaboration agreement with National Community Oncology Dispensing Association, Inc. to educate oncology community about Phexxi. Evofem Biosciences, Inc. is headquartered in San Diego, California. Show More...
-
Website http://www.evofem.com
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 0.01 USD
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share USD -5.5 -10.55 -32.16 -18.91 -5.66 -55.78 -5.74 -1.99 -1.72 Dividends USD Payout Ratio % * Shares Mil 1.0 1.0 2.0 2.0 2.0 22.0 40.0 46.0 Book Value Per Share * USD 4.62 14.28 5.98 2.1 -0.39 0.5 0.02 Free Cash Flow Per Share * USD -7.42 -12.13 -11.74 -3.79 -2.46 -1.53 Return on Assets % -61.05 -173.07 -26.57 -73.77 -49.19 -118.02 -495.48 -859.27 Financial Leverage (Average) 1.18 1.68 1.08 1.52 1.81 15.32 Return on Equity % -252.9 -96.92 -72.89 -136.7 Return on Invested Capital % -74.55 -75.42 -67.42 -137.4 Interest Coverage -7.36 -263.33 -27.86 -37.06 -11.57 Current Ratio 6.59 2.95 40.26 4.37 13.86 2.85 0.09 2.09 0.95 Quick Ratio 5.82 2.86 39.77 4.15 12.72 2.42 0.06 1.93 0.74 Debt/Equity 0.15 0.3 0.16